Vertex Pharmaceuticals Inc. buy Barclays PLC
Start price
06.02.24
/
50%
€387.70
Target price
06.02.25
€439.24
Performance (%)
19.98%
End price
07.02.25
€465.15
Summary
This prediction ended on 07.02.25 with a price of €465.15. The prediction had a final performance of 19.98%. Barclays_PLC has a follow-up prediction for Vertex Pharmaceuticals Inc. where he still thinks Vertex Pharmaceuticals Inc. is a Buy. Barclays_PLC has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Vertex Pharmaceuticals Inc. | 2.412% | 2.412% | -6.387% |
| iShares Core DAX® | 0,46 % | -2,00 % | 9,98 % |
| iShares Nasdaq 100 | -1,79 % | -5,74 % | -0,78 % |
| iShares Nikkei 225® | 5,12 % | 9,09 % | 28,82 % |
| iShares S&P 500 | -1,76 % | -3,67 % | -0,54 % |
Comments by Barclays_PLC for this prediction
In the thread Trading Vertex Pharmaceuticals Inc.
Die von Barclays_PLC gewählte maximale Laufzeit wurde überschritten
In the thread Vertex Pharmaceuticals Inc. diskutieren
Vertex Pharmaceuticals Incorporated (NASDAQ: VRTX) had its price target raised by analysts at Barclays PLC from $446.00 to $472.00. They now have an "overweight" rating on the stock.
Ratings data for VRTX provided by MarketBeat
Current prediction by Barclays_PLC for Vertex Pharmaceuticals Inc.
Vertex Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€396.70
27.01.26
27.01.26
-
27.01.27
27.01.27
4.37%
13.02.26
13.02.26
Stopped prediction by Barclays_PLC for Vertex Pharmaceuticals Inc.
Vertex Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€327.60
11.12.23
11.12.23
€385.41
11.12.24
11.12.24
35.84%
12.12.24
12.12.24